Top 5 Medical Angel Investors in Italy in December 2024
A list of 5 angel investors that invest in Medical startups based in Italy. We rank investors based on the number of investments they made in Medical companies from Italy. We update this investor list every month.Top 5 Medical Angel Investors in Italy in December 2024
Investor | Medical Italy investments |
---|---|
Luca Trevisan | 2 |
Rosario Bifulco | 1 |
Giovanni Leo | 1 |
Barbara Castellano | 1 |
Andrea Venturelli | 1 |
Luca Trevisan Sales Manager and Business Coordinator.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Series A
- Italy
Portfolio highlights
- I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
Rosario Bifulco, president of the auction house Finarte S.p.A.
Show more
Investment focus
- Art, Medical, Blockchain
- Seed, Pre-Seed, Series A
- Italy
Portfolio highlights
- I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
- Reasoned Art — Reasoned Art is the Italian gallery dedicated to CryptoArt. it selects the best digital artists worldwide, curates physical and virtual exhibitions, and certifies the authenticity of works allowing their sale through NFT.
Giovanni Leo is the Partner at Efficient Frontier Investing.
Show more
Investment focus
- Health Care, Medical Device, Medical
- Seed, Series B
- Switzerland, Italy
Portfolio highlights
- Medyria — Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland.
- Terapet — Terapet was founded at CERN by two physicists – Christina Vallgren and Marcus Palm – along with Professor Raymond Miralbell from the Geneva University Hospitals (HUG). They have already proven the feasibility of their concept and are now developing an initial version for market launch.
- CV Lab — CV Lab is the first incubator fully focused on cardiovascular innovation in Europe. It supports the most promising ideas through patenting, prototyping, and proof of concept until they mature enough to give life to a spin-off and meet international capitals. CVLab puts to good use the experience of entrepreneurs and specialists with strongexpertise in biomedical. The company collaborates with experts in the field. CVLab is a lean organization, close to researchers and clinical needs.
Laura Iris Ferro
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Pre-Seed, Funding Round
- Italy
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
- CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Andrea Venturelli - Venture Partner @ Innogest Capital
Show more
Investment focus
- Art, Events, Retail
- Seed
- Italy, United States
Portfolio highlights
- Arcadia Earth — WHAT IS IT? Arcadia Earth is a large scale multi-sensorial journey through underwater worlds, fantasy lands, and inspirational art installations.
- CV Lab — CV Lab is the first incubator fully focused on cardiovascular innovation in Europe. It supports the most promising ideas through patenting, prototyping, and proof of concept until they mature enough to give life to a spin-off and meet international capitals. CVLab puts to good use the experience of entrepreneurs and specialists with strongexpertise in biomedical. The company collaborates with experts in the field. CVLab is a lean organization, close to researchers and clinical needs.
Investors by industry
Biotech
Proptech
Gaming
FinTech
Health Care
Community
Google
Marketplace
Climate
Consumer
Artificial intelligence
Impact
Energy
Hardware
EdTech
Sustainability
Venture Capital
Clean Energy
B2B
Real Estate
Publishing
Payments
Big Data
Retail
Organic Food
Web3
Education
Finance
Food and Beverage
Video Games
Infrastructure
Financial Services
Photography
Beauty
Medical
Wellness
Social Media
Social Network
Android
Construction
Art
Local
Legal
Digital Media
Manufacturing
eSports
Sports
Music
Mobile
Internet
Enterprise Software
Franchise
Email
Travel
Mobile Advertising
Biotechnology
Recruiting
Hospitality
Fitness
Platforms
Cannabis
Medical Device
Social
Automotive
Crowdfunding
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Film
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Social Impact
Restaurants
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Canada
New Zealand
Ireland
United States
Qatar
Saudi Arabia
Spain
Sri Lanka
China
Middle East
Africa
Indonesia
Europe
Armenia
Singapore
Oceania
Brazil
Japan
South Africa
Vietnam
LATAM
Asia
Denmark
Costa Rica
Bermuda
Egypt
Croatia
Gibraltar
Algeria
Estonia
Ecuador
Greece
Chile
Bulgaria
Ethiopia
Hong Kong
Faroe Islands
France
Ghana
Czech Republic
Hungary
Lebanon
Mali
Liberia
Malta
Liechtenstein
Malaysia
Italy
Panama
Myanmar
Mauritius
Nicaragua
Philippines
Lithuania
Israel
Jersey
Norway
Morocco
Mexico
Peru
Kuwait
Puerto Rico
Tunisia
Uganda
Sierra Leone
Senegal
San Marino
Uzbekistan
Seychelles
Togo
El Salvador
Rwanda
Russian Federation
Tanzania
Ukraine
Zimbabwe
Uruguay
Serbia
Taiwan
Venezuela
Tajikistan
Sweden
Turkey
Poland
Thailand
Zambia
Portugal
Slovenia
Dominican Republic
Azerbaijan
Iraq
Iceland
Bahamas
Namibia
Nigeria
Georgia
United Arab Emirates
Belgium
Jamaica
Honduras
Finland
Bahrain
Bolivia
Isle of Man
Belarus
Luxembourg
Belize
Barbados
Albania
Pakistan
Kenya
Bangladesh
Argentina
Grenada
Jordan
Romania
Kazakhstan
Cayman Islands
Cambodia
Guatemala
Cyprus
Latvia
Oman
Cameroon
Austria
Switzerland
Colombia
Marshall Islands
Angel Investors in Italy by industry
Restaurants
Crowdfunding
Venture Capital
Transportation
Financial Services
Cryptocurrency
Finance
Payments
Wine And Spirits
Medical Device
Manufacturing
Digital Media
Mobile
Blockchain
Legal
Software
Sports
EdTech
Travel
Automotive
Biotechnology
FinTech
Enterprise
Health Care
Consumer
Biotech
Energy
Sustainability
Impact
Marketplace
Artificial intelligence
Community
Hardware
Gaming
Fashion
Retail
Web3
SaaS
Real Estate
Internet
Music
Education
Publishing
Social Impact
Medical
Wellness
Agriculture (agtech)
Media (entertainment)
Food and Beverage
InsurTech
Proptech
Climate